Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRDN · against 328 other Healthcare companies of similar size
Ranked #113 of 329 · scores higher than 66% of peers
Bars: peers in each 10-point band of the growth score43 peers with a growth score of 60–69, including GRDN · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | GRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 328 reported | 10.3% | 7.0% | 57% | 33% | |
| Earnings per share growthHigher is better · 197 reported | Not reported | 10.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 321 reported | 16.8% | 7.9% | 75% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 106 | 1.3B USD | 72 | 44 | |
| 111 | 22.0B SEK (≈$2.2B) | 71 | 51 | |
| 112 | 4.0B USD | 69 | 56 | |
| 113 | 32.6B HKD (≈$4.2B) | 68 | 60 | |
| 113 | 2.6B USD | 68 | 66 | |
| 115 | 2.5B USD | 67 | 79 | |
| 115 | 2.4B USD | 67 | 64 | |
| 115 | 21.5B DKK (≈$3.2B) | 67 | 58 | |
| 115 | 15.7B SEK (≈$1.6B) | 67 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score